VLP purification patent granted in EU

Artes is pleased to announce the issuance of a new patent for their VLP development  and production platform. The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension”.  

ARTES and Burnet Institute publish data on new malaria vaccine candidates

For more information: Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice.

ARTES backs “Initiative against Corona”

Never again 2020: Let’s get vaccinated – “Initiative against Corona” calls for vaccinations Health service provider NOVENTI and the four leading vaccine manufacturers in Germany want to increase the population’s willingness to vaccinate through a Germany-wide campaign – “Dispute must give way to factual clarification” posters for all 19,000 pharmacies in Germany, among others “Never […]